Thursday, March 26, 2020 3:11:19 PM
- These run-ups have happened a few times before;
- Share holders become excited at the move, but more so the volume and then
believe in a highly bullish move, frequently an exaggerated belief;
- During these times, with Israel on virtual shut-down, movement on clinical trials will likely have come to a halt.
This volume is likely an anomaly, and while I am loaded up, I'm not going to get overly excited, nor would I purchase more stock.
Just my thoughts on a high-volume day here at the OWCP shop.
Much luck
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM